Skip to main content
CRA Foundation Contact Us
Clinical Guidelines CRA Annual Scientific Meeting
0
News & Events
Members
Clinical Resources & Tools
Education & Career Advancements
Research & Grants
About Us
Clinical Guidelines CRA Annual Scientific Meeting
CRA Foundation Contact Us
Go back to /resources Back
CRA Workforce and Wellness Surveys

CRA Workforce and Wellness Surveys

August 24, 2023

The Canadian Rheumatology Association (CRA) Workforce and Wellness surveys are periodically updated to monitor the Canadian rheumatology workforce characteristics.

Additional Resources
CRA Position Statement

Position Statements on Priority Areas to Support the Sustainability of the Canadian Rheumatology Workforce

Click Here
The Journal of Rheumatology

An Overview of Reviews to Inform Organization-level Interventions to Address Burnout in Rheumatologists

Click Here
The Journal of Rheumatology

Results From the 2020 Canadian Rheumatology Association’s Workforce and Wellness Survey

Click Hree
The Journal of Rheumatology

Stand Up and Be Counted: Measuring and Mapping the Rheumatology Workforce in Canada.

Click Here
The Journal of Rheumatology

Measuring the Rheumatology Workforce in Canada: A Literature Review

Click Here
Planning for the rheumatologist workforce: Factors associated with work hours and volumes
Click Here
CRAJ

Rheumatology workforce in Canada

Click Here
CRAJ

So we stood up and got counted, now what?

Click Here
CRAJ

Stand Up and Be Counted

Click Here
Measuring and Mapping the Rheumatology Workforce in Canada
Click Here
Measuring the Rheumatologist Workforce in Canada: Stand Up and Be Counted!
Click Here
Measuring the Rheumatologist Workforce in Canada: Preliminary Results of the Stand-up and be Counted Survey.
Click Here
Related Resources View All
Clinical Guidelines
CRA living guidelines for the pharmacological management of rheumatoid arthritis with disease-modifying anti-rheumatic drugs
This Canadian Rheumatology Association (CRA) guideline provides contemporary recommendations for the pharmacological management of rheumatoid arthritis (RA) with disease-modifying anti-rheumatic drug (DMARD) therapy. Recommendations are developed using the GRADE approach with a multidisciplinary panel composed of rheumatologists, researchers, methodologists, and […]
April 23, 2026
Clinical Guidelines
Canadian Rheumatology Association/Spondyloarthritis Research Consortium of Canada Living Guideline for the Management of Axial Spondyloarthritis
The management of axial spondyloarthritis (axSpA) is a complex and rapidly changing field for Canadian rheumatologists. The Spondyloarthritis Research Consortium of Canada (SPARCC) and the Canadian Rheumatology Association (CRA) last updated treatment recommendations for the management of axSpA in 2014(1,2). […]
April 22, 2026
Clinical Guidelines
CRA/CanRIO guidelines for the management of baseline immunosuppression in individuals with pre-existing rheumatic diseases initiating immune checkpoint inhibitors
This living guideline offers up-to-date guidance on the management of baseline immunosuppression (IS) for pre-existing rheumatic diseases (PRDs) when initiating cancer immunotherapy with immune checkpoint inhibitors (ICIs). Split into 2 parts, this guideline provides contemporary baseline IS recommendations for individuals […]
September 1, 2025